drugset / Trial / NCT06054321
Psychopharmacotherapy for Depressive Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary purpose of this study is to compare the short (12 week) and long-term (1-year) efficacy and the tolerability between stepwise psychopharmacotherapy and antidepressant monotherapy for 12 weeks in adult patients with major depressive disorders, stratified by the multimodal serum biomarker scores.
Timeline
- Start
- 2022-08-03
- Primary completion
- 2028-12-31
- Completion
- 2030-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | — | — |
| Comparator | Escitalopram | Small molecule | — | — |
| Subject | Lithium | Unknown | — | — |
| Subject | Mirtazapine | Other / unclassified | — | — |